Inventor · disambiguated record
Thomas B. Ottoboni
Also filed as: OTTOBONI THOMAS B
53 granted patents·32 pending applications·1,165 citations·filing 1991–2025
99Inventor score
Files withHERON THERAPEUTICS INC47POINT BIOMEDICAL CORP14CLOROX CO4OTTOBONI THOMAS B4INSITE VISION INC2
Top patents by PatentIndex Score
85 records- 0199US11173118B2Emulsion formulations of an NK-1 receptor antagonist and uses thereofHERON THERAPEUTICS INC·Filed 2020·Granted Nov 16, 2021·13 cites·18 claims
- 0298US11878074B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2021·Granted Jan 23, 2024·7 cites·14 claims
- 0398US11744800B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2022·Granted Sep 5, 2023·7 cites·30 claims
- 0498US10953018B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2019·Granted Mar 23, 2021·12 cites·18 claims
- 0598US10624850B2Emulsion formulations of an NK-1 receptor antagonist and uses thereofHERON THERAPEUTICS INC·Filed 2018·Granted Apr 21, 2020·12 cites·16 claims
- 0698US9974742B2Emulsion formulations of an NK-1 receptor antagonist and uses thereofHERON THERAPEUTICS INC·Filed 2016·Granted May 22, 2018·18 cites·23 claims
- 0798US6207180B1Intravesical drug deliveryFiled 2000·Granted Mar 27, 2001·125 cites·19 claims
- 0897US9974793B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·18 cites·22 claims
- 0997US9808465B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2015·Granted Nov 7, 2017·23 cites·15 claims
- 1097US9561229B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2016·Granted Feb 7, 2017·22 cites·21 claims
- 1197US6896659B2Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragilityPOINT BIOMEDICAL CORP·Filed 2001·Granted May 24, 2005·90 cites·25 claims
- 1296US10500208B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2017·Granted Dec 10, 2019·15 cites·17 claims
- 1396US9974794B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·14 cites·21 claims
- 1496US9801945B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2016·Granted Oct 31, 2017·9 cites·30 claims
- 1596US9694079B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2016·Granted Jul 4, 2017·19 cites·14 claims
- 1696US6524608B2Intravesical drug delivery systemPOINT BIOMEDICAL CORP·Filed 2001·Granted Feb 25, 2003·82 cites·40 claims
- 1795US11413350B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2020·Granted Aug 16, 2022·3 cites·110 claims
- 1895US6039967AIntravesical drug delivery systemPOINT BIOMEDICAL CORP·Filed 1998·Granted Mar 21, 2000·123 cites·29 claims
- 1994US6193951B1Microparticles useful as ultrasonic contrast agentsPOINT BIOMEDICAL CORP·Filed 1998·Granted Feb 27, 2001·117 cites·41 claims
- 2092US10632199B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2018·Granted Apr 28, 2020·3 cites·20 claims
- 2192US10213510B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2015·Granted Feb 26, 2019·10 cites·19 claims
- 2291US12290520B2Methods of use of emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2024·Granted May 6, 2025·0 cites·24 claims
- 2391US10098957B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·3 cites·24 claims
- 2489US5667735AOpthalmic mold coatings2C OPTICS INC·Filed 1996·Granted Sep 16, 1997·73 cites·26 claims
- 2587US12115255B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2024·Granted Oct 15, 2024·0 cites·30 claims
- 2687US11253504B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2019·Granted Feb 22, 2022·1 cites·15 claims
- 2786US12115254B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2024·Granted Oct 15, 2024·0 cites·30 claims
- 2885US11083730B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2016·Granted Aug 10, 2021·2 cites·54 claims
- 2985US11083797B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2017·Granted Aug 10, 2021·1 cites·20 claims
- 3085US10898575B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2017·Granted Jan 26, 2021·3 cites·79 claims
- 3184US2025228867A1Methods of use of emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3284US2024238197A1Methods of use of emulsion formulations of an nk-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3384US2025161458A1Compositions of a polyorthoester and an organic acid excipientHERON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3483US10398686B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2017·Granted Sep 3, 2019·2 cites·10 claims
- 3582US9446036B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2014·Granted Sep 20, 2016·5 cites·14 claims
- 3682US5837226AOcular microsphere delivery systemVITAPHORE CORP C O INTEGRA LIF·Filed 1995·Granted Nov 17, 1998·85 cites·2 claims
- 3782US5731005AHydrogel-based microsphere drug delivery systemsVITAPHORE CORP·Filed 1995·Granted Mar 24, 1998·71 cites·8 claims
- 3881US12318376B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2022·Granted Jun 3, 2025·0 cites·19 claims
- 3980US9913909B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2016·Granted Mar 13, 2018·2 cites·15 claims
- 4080US9592227B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2014·Granted Mar 14, 2017·3 cites·25 claims
- 4177US10980886B2Compositions of a polyorthoester and an organic acid excipientHERON THERAPEUTICS INC·Filed 2015·Granted Apr 20, 2021·1 cites·7 claims
- 4277US2021186981A1Methods of use of emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4376US8460637B2Reconstitutable microsphere compositions useful as ultrasonic contrast agentsOTTOBONI THOMAS B·Filed 2011·Granted Jun 11, 2013·1 cites·7 claims
- 4476US5269962AOxidant composition containing stable bleach activator granulesCLOROX CO·Filed 1991·Granted Dec 14, 1993·38 cites·28 claims
- 4575US2021330796A1Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4675US2009081130A1Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstreamPOINT BIOMEDICAL CORP·Filed 2008·Application pending·0 cites
- 4774US11844837B2Compositions of a polyorthoester and an organic acid excipientHERON THERAPEUTICS INC·Filed 2021·Granted Dec 19, 2023·0 cites·9 claims
- 4873US5767153ASustained release emulsionsINSITE VISION INC·Filed 1995·Granted Jun 16, 1998·35 cites·5 claims
- 4971US9744163B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2014·Granted Aug 29, 2017·1 cites·21 claims
- 5071US2025387487A1Compositions of a polyorthoester and an organic acid excipientHERON THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas B. Ottoboni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →